Core Points - A class action lawsuit has been filed against Marex Group plc on behalf of investors who purchased shares between May 16, 2024, and August 5, 2025 [1][2] - The lawsuit follows a report by NINGI Research that alleged financial improprieties, including a multi-year accounting scheme and misleading disclosures [3][4] - Marex is accused of concealing nearly $1 billion in off-balance-sheet derivatives, which inflated profits and operating cash flow [4] Company Overview - Marex Group plc is headquartered in London and provides global financial services, including trading, clearing, and risk management [2] Allegations and Impact - The complaint details discrepancies in intercompany receivables and loans across over 56 entities, amounting to multi-million-dollar discrepancies [3] - Following the release of the report, Marex's stock price fell by $2.33, or 6.2%, closing at $35.31, resulting in significant investor losses [4]
NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline